BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10322765)

  • 1. [Some aspects of the study of gonorrhea vaccine].
    He F; Zhao L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):248-50. PubMed ID: 10322765
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.
    Wetzler LM; Blake MS; Gotschlich EC
    Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential.
    Perrollet H; Guinet RM
    Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ways and prospects of producing gonococcal vaccine].
    Bednova VN; Dmitriev GA; Pasternak NI
    Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694
    [No Abstract]   [Full Text] [Related]  

  • 5. Gonococcal cell wall lectin-adhesin with vaccine potential.
    Perrollet H; Guinet RM
    Lancet; 1986 May; 1(8492):1269-70. PubMed ID: 2872407
    [No Abstract]   [Full Text] [Related]  

  • 6. A vaccine against gonorrhoea?
    Br Med J; 1977 Oct; 2(6092):917-8. PubMed ID: 410476
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary studies on the development of a gonococcal vaccine.
    Greenberg I; Diena BB; Kenny CP; Znamirowski R
    Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae.
    Plante M; Jerse A; Hamel J; Couture F; Rioux CR; Brodeur BR; Martin D
    J Infect Dis; 2000 Sep; 182(3):848-55. PubMed ID: 10950780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a gonococcal protein I vaccine.
    Blake MS; Wetzler LM; Gotschlich EC; Rice PA
    Adv Exp Med Biol; 1989; 251():315-27. PubMed ID: 2514585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and expression of the major outer membrane protein PI of Neisseria gonorrhoeae in Escherichia coli].
    Wen H; Zhan L; Wang DL; Xu X; Yong G; Pei XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):196-9. PubMed ID: 15807265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could vaccination against Neisseria gonorrhoeae be on the horizon?
    Russell MW
    Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines for gonorrhea: where are we on the curve?
    Blake MS; Wetzler LM
    Trends Microbiol; 1995 Dec; 3(12):469-74. PubMed ID: 8800838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonococcal infection: a model of molecular pathogenesis.
    Britigan BE; Cohen MS; Sparling PF
    N Engl J Med; 1985 Jun; 312(26):1683-94. PubMed ID: 2860565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protective properties of gonococcal vaccines].
    Ovchinnikov NM; Timchenko GF
    Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
    [No Abstract]   [Full Text] [Related]  

  • 16. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.
    Starnino S; Leuzzi R; Ghisetti V; De Francesco MA; Cusini M; Impara G; Galluppi E; Pizza M; Stefanelli P
    New Microbiol; 2010 Apr; 33(2):167-70. PubMed ID: 20518279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyrogenal-vaccine therapy of men with gonorrhea].
    Shamshin NF; Malykh VA
    Vestn Dermatol Venerol; 1980 Nov; (11):62-4. PubMed ID: 6778014
    [No Abstract]   [Full Text] [Related]  

  • 19. Gonococcal vaccine studies in Inuvik.
    Greenberg L; Diena BB; Ashton FA; Wallace R; Kenny CP; Znamirowski R; Ferrari H; Atkinson J
    Can J Public Health; 1974; 65(1):29-33. PubMed ID: 4205640
    [No Abstract]   [Full Text] [Related]  

  • 20. My battle against gonorrhea.
    Coulehan J
    Ann Intern Med; 2011 Aug; 155(3):198-200. PubMed ID: 21810714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.